Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology

Open access
Jiao, Bin, Li, Rihui, Zhou, Hui, Qing, Kunqiang, Liu, Hui, Pan, Hefu, Lei, Yanqin, Fu, Wenjin, Wang, Xiaoan, Xiao, Xuewen, Liu, Xixi, Yang, Qijie, Liao, Xinxin, Zhou, Yafang, Fang, Liangjuan, Dong, Yanbin, Yang, Yuanhao, Jiang, Haiyan, Huang, Sha, Shen, Lu · 2023 · Alzheimer's Research & Therapy

Abstract

Background: Electroencephalogram (EEG) has emerged as a non-invasive tool to detect the aberrant neuronal activity related to different stages of Alzheimer’s disease (AD). However, the effectiveness of EEG in the precise diagnosis and assessment of AD and its preclinical stage, amnestic mild cognitive impairment (MCI), has yet to be fully elucidated. In this study, we aimed to identify key EEG biomarkers that are effective in distinguishing patients at the early stage of AD and monitoring the progression of AD. Methods: A total of 890 participants, including 189 patients with MCI, 330 patients with AD, 125 patients with other dementias (frontotemporal dementia, dementia with Lewy bodies, and vascular cognitive impairment), and 246 healthy controls (HC) were enrolled. Biomarkers were extracted from resting-state EEG recordings for a three-level classification of HC, MCI, and AD. The optimal EEG biomarkers were then identified based on the classification performance. Random forest regression was used to train a series of models by combining participants’ EEG biomarkers, demographic information (i.e., sex, age), CSF biomarkers, and APOE phenotype for assessing the disease progression and individual’s cognitive function. Results: The identified EEG biomarkers achieved over 70% accuracy in the three-level classification of HC, MCI, and AD. Among all six groups, the most prominent effects of AD-linked neurodegeneration on EEG metrics were localized at parieto-occipital regions. In the cross-validation predictive analyses, the optimal EEG features were more effective than the CSF + APOE biomarkers in predicting the age of onset and disease course, whereas the combination of EEG + CSF + APOE measures achieved the best performance for all targets of prediction. Conclusions: Our study indicates that EEG can be used as a useful screening tool for the diagnosis and disease progression evaluation of MCI and AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13195-023-01181-1

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 192

Metadata

Authors
Jiao, B., Li, R., Zhou, H., Qing, K., Liu, H., Pan, H., Lei, Y., Fu, W., Wang, X., Xiao, X., Liu, X., Yang, Q., Liao, X., Zhou, Y., Fang, L., Dong, Y., Yang, Y., Jiang, H., Huang, S., & Shen, L.
Venue
Alzheimer's Research & Therapy
Published
2023-02-10
Volume
15
Issue
1
Pages
32-32
ISSN
1758-9193 (ISSN-L)
OpenAlex
W4319982255
Cited by
192
References
10
FWCI
34.35
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology. https://app.cochat.ai/papers/10.1186/s13195-023-01181-1
The paper
Jiao, B., Li, R., Zhou, H., Qing, K., Liu, H., Pan, H., Lei, Y., Fu, W., Wang, X., Xiao, X., Liu, X., Yang, Q., Liao, X., Zhou, Y., Fang, L., Dong, Y., Yang, Y., Jiang, H., Huang, S., & Shen, L. (2023). Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-023-01181-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.